Licensing & Partnership
15.3M+ condition-confirmed patient inquiries. Every record is a real person who self-identified on a condition-specific intake — already past the impression, the click, and the form. The largest exclusive consented-intent asset in healthcare, licensed four different ways.
The Asset
The 15.3M figure isn't an audience built from third-party signals, modeled lookalikes, or impression-level proxies. Every record is a real person who completed the work a pharma campaign is built to drive — they saw an unbranded condition ad, clicked through, and either filled out a condition-specific landing page or called in through a click-to-call or live transfer line. They self-identified. They gave consent. They asked for information.
That's the action a brand's entire media budget is trying to produce. Summit already produced it — across a decade of unbranded campaigns, at scale no competitor can replicate, exclusive for 20 years.
T1's 140,216 Tx-verified patients, T2's 218,071 Dx-qualified records, the 386,000+ cross-tier matches, and 1,008,348 Rx fulfillment events are proof T3 converts downstream — not the headline asset. The headline asset is T3.
The Four Structures
Every license includes the same operational foundation — the data layer, bilateral identity protocol, and access to Exchange for activation. What differs is the scope of exclusivity, the commercial terms, and the competitive lockout against other licensees in your category.
At a Glance
From Conversation to Activation
The right structure depends on what you're trying to build. A scoping call is the fastest way to find out. We'll walk through your target conditions, audience needs, and competitive context — and return a structure recommendation within one week.